Benzinga | Aug 11, 2021 11:23AM EDT

HC Wainwright & Co. Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $170

HC Wainwright & Co. analyst Ed Arce maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and lowers the price target from $184 to $170.